Viewing nowInhifla Tablet (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 200604277 · Notified 2006.05.03 · Insurance code 648101690
Improvement of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
This medication is used for the improvement of atherosclerotic symptoms caused by ischemic stroke, myocardial infarction, or peripheral arterial disease. It also helps reduce the risk of death, myocardial infarction, and stroke due to cardiovascular complications after medical treatment or intervention in patients with acute coronary syndrome, especially those with unstable angina or non-ST elevation myocardial infarction. Additionally, in patients with atrial fibrillation who have vascular risk factors and are not suitable for vitamin K antagonists with low bleeding risk, it is effective in reducing the risks of stroke and thromboembolism. This medication is used to reduce various cardiovascular diseases and thromboembolic-related risks.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the first day with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. For patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be administered with or without food.
This medication prevents blood from clotting by inhibiting platelet aggregation. The effectiveness of this medication may be reduced in individuals with genetic variations leading to low function of a specific enzyme (CYP2C19); alternative treatments should be considered in such cases. Concomitant use with drugs that activate certain enzymes may increase medication concentrations and raise the risk of bleeding, hence should be avoided. Patients with a known allergy to this medication or those with bleeding, severely impaired liver function, nursing women, or individuals with certain genetic conditions should not take this medication. Patients at high risk of bleeding or those scheduled for surgery must exercise caution when taking this medication, and if bleeding symptoms occur, they should consult a physician immediately. The risk of bleeding may increase if taken with other medications that also increase bleeding risk. During treatment with this medication, bleeding may take longer to stop; notify healthcare professionals if bleeding is severe or prolonged. This medication can rarely cause thrombocytopenia or serious blood disorders; visit a hospital immediately if fever or signs of infection occur. Possible side effects include gastrointestinal disturbances, headache, dizziness, rash, etc., though these are usually mild. During pregnancy, the risk to the fetus is not significant; however, due to the potential for bleeding during delivery, discontinuation before childbirth is recommended. During breastfeeding, this medication may be excreted in breast milk, and it's advisable to discuss whether to continue or discontinue breastfeeding with a physician. Elderly patients or those with impaired kidney function may have a higher risk of bleeding and should use caution. Overdose may increase bleeding risk, and as there is no specific antidote, treatment such as platelet transfusion may be necessary in case of severe bleeding. The safety and efficacy of this medication in children have not been established. During the course of this medication, inform your physician about the current use of this medication before starting new therapies or surgeries. This medication should be kept out of reach of children, and care should be taken not to transfer it to other containers as this may affect its quality.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is best to keep it at room temperature, between 1 to 30 degrees Celsius.
Pink round film-coated tablets
30 tablets (10 tablets/Alu-Alu X 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.